Health · 1 sources covering this

STAT+: Silence Therapeutics aims at Takeda with new data in rare blood cancer

A rare blood cancer drug from Silence Therapeutics showed strong results in a trial, potentially setting it up to compete with a Takeda medicine.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

STATCenter·3h ago
STAT+: Silence Therapeutics aims at Takeda with new data in rare blood cancer
A rare blood cancer drug from Silence Therapeutics showed strong results in a trial, potentially setting it up to compete with a Takeda medicine.
Read at STAT →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/45f184d3a93642e6a7eba8e8d8196eda78dc52cc"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Silence Therapeutics aims at Takeda with new data in rare blood cancer"></iframe>

STAT+: Silence Therapeutics aims at Takeda with new data in rare blood cancer

How 1 sources are covering this

STAT+: Silence Therapeutics aims at Takeda with new data in rare blood cancer

More from Health

STAT+: Pharmalittle: We’re reading about a Sanofi drug shortage, a Jazz Pharma deal, and more

STAT+: Sionna’s experimental cystic fibrosis pill falls flat in mid-stage trial

STAT+: Heart failure drug from Tenax Therapeutics fails in pivotal study

Some disabled people want to advance their careers. They say Medicaid rules stop them

Reader

Trust & legal

Across the network

How 1 sources are covering this

STAT+: Silence Therapeutics aims at Takeda with new data in rare blood cancer

More from Health

STAT+: Pharmalittle: We&#8217;re reading about a Sanofi drug shortage, a Jazz Pharma deal, and more

STAT+: Sionna’s experimental cystic fibrosis pill falls flat in mid-stage trial

STAT+: Heart failure drug from Tenax Therapeutics fails in pivotal study

Some disabled people want to advance their careers. They say Medicaid rules stop them

Reader

Trust & legal

Across the network

STAT+: Pharmalittle: We’re reading about a Sanofi drug shortage, a Jazz Pharma deal, and more